OCULAR CHANGES IN METASTATIC MELANOMA PATIENTS TREATED WITH MEK INHIBITOR COBIMETINIB AND BRAF INHIBITOR VEMURAFENIB. Radiol Oncol. 2018;52(2). Accessed July 30, 2026. https://www.ojstest.computing.si/index.php/ro/article/view/2930